Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.

@article{Torii2010InfliximabMI,
  title={Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.},
  author={Hideshi Torii and Hidemi Nakagawa},
  journal={Journal of dermatological science},
  year={2010},
  volume={59 1},
  pages={40-9}
}
BACKGROUND A clinical trial of infliximab in psoriasis has not yet been performed in Asian populations, although infliximab has been approved for the indications of psoriatic arthritis and plaque psoriasis in the US and the EU. OBJECTIVE This study aims to validate the efficacy and safety of infliximab in Japanese patients with plaque psoriasis and psoriatic arthritis. METHODS Patients with moderate-to-severe psoriasis, including psoriatic arthritis, were randomized to the induction therapy… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 20 references

Similar Papers

Loading similar papers…